155 research outputs found
Does a joint development and dissemination of multidisciplinary guidelines improve prescribing behaviour: a pre/post study with concurrent control group and a randomised trial
BACKGROUND: It is difficult to keep control over prescribing behaviour in general practices. The purpose of this study was to assess the effects of a dissemination strategy of multidisciplinary guidelines on the volume of drug prescribing. METHODS: The study included two designs, a quasi-experimental pre/post study with concurrent control group and a random sample of GPs within the intervention group. The intervention area with 53 GPs was compared with a control group of 54 randomly selected GPs in the south and centre of the Netherlands. Additionally, a randomisation was executed in the intervention group to create two arms with 27 GPs who were more intensively involved in the development of the guideline and 26 GPs in the control group. A multidisciplinary committee developed prescription guidelines. Subsequently these guidelines were disseminated to all GPs in the intervention region. Additional effects were studied in the subgroup trial in which GPs were invited to be more intensively involved in the guideline development procedure. The guidelines contained 14 recommendations on antibiotics, asthma/COPD drugs and cholesterol drugs The main outcome measures were prescription data of a three-year period (one year before and 2 years after guideline dissemination) and proportion of change according to recommendations. RESULTS: Significant short-term improvements were seen for one recommendation: mupirocin. Long-term changes were found for cholesterol drug prescriptions. No additional changes were seen for the randomised controlled study in the subgroup. GPs did not take up the invitation for involvement. CONCLUSION: Disseminating multidisciplinary guidelines that were developed within a region, has no clear effect on prescribing behaviour even though GPs and specialists were involved more intensively in their development. Apparently, more effort is needed to bring about change
Implementing cognitive behavior therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis
Contains fulltext :
69822.pdf (publisher's version ) (Open Access
Applications of cyclotron based ion scattering
Ion scattering experiments have been performed with a 3-30 MeV AVF cyclotron. The wide range of available energies combined with proper beam handling allows many scattering techniques to perform. At first an example of ordinary Rutherford backscattering spectrometry will be demonstrated on model catalysts as studied in surface chemistry. High energy backscattering spectrometIy with 8.8 MeV He ions, which enhances the sensitivity for oxygen, has been applied to study the oxygen removal from corroded archaeological artefacts upon treatment with a H, plasma. Elastic recoil detection analysis will be shown feasible with He ions having incident energies between 10 and 15 MeV once combined with a thin film detector. The development of a setup for ion channeling experiments with the cyclotron is reported and first results promise to increase the angular resolution in lattice deformation studies
Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes
Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy
The National Institute for Health and Care Excellence (NICE) invited the company that manufactures ramucirumab (Cyramza®, Eli Lilly and Company) to submit evidence of the clinical and cost effectiveness of the drug administered alone (monotherapy) or with paclitaxel (combination therapy) for treating adults with advanced gastric cancer or gastro-oesophageal junction (GC/GOJ) adenocarcinoma that were previously treated with chemotherapy, as part of the Institute’s single technology appraisal (STA) process. Kleijnen Systematic Reviews Ltd (KSR), in collaboration with Erasmus University Rotterdam, was commissioned to act as the Evidence Review Group (ERG). This paper describes the company’s submission, the ERG review, and NICE’s subsequent decisions. Clinical effectiveness evidence for ramucirumab monotherapy (RAM), compared with best supportive care (BSC), was based on data from the REGARD trial. Clinical effectiveness evidence for ramucirumab combination therapy (RAM + PAC), compared with paclitaxel monotherapy (PAC), was based on data from the RAINBOW trial. In addition, the company undertook a network meta-analysis (NMA) to compare RAM + PAC with BSC and docetaxel. Cost-ef
Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes
__Abstract__
Background: In the absence of a gold standard, a panel of experts can be invited to assign a reference diagnosis
for use in research. Available literature offers limited guidance on assembling and working with an expert panel
for this purpose. We aimed to develop a protocol for an expert panel consensus diagnosis and evaluated its
applicability in a pilot project.
Methods: An adjusted Delphi method was used, which started with the assessment of clinical vignettes by 3
experts individually, followed by a consensus discussion meeting to solve diagnostic discrepancies. A panel
facilitator ensured that all experts were able to express their views, and encouraged the use of argumentation to
arrive at a specific diagnosis, until consensus was reached by all experts. Eleven vignettes of patients suspected of
having a primary neurodegenerative disease were presented to the experts. Clinical information was provided
stepwise and included medical history, neurological, physical and cognitive function, brain MRI scan, and follow-up
assessments over 2 years. After the consensus discussion meeting, the procedure was evaluated by the experts.
Results: The average degree of consensus for the reference diagnosis increased from 52% after individual
assessment of the vignettes to 94% after the consensus discussion meeting. Average confidence in the diagnosis
after individual assessment was 85%. This did not increase after the consensus discussion meeting. The process
evaluation led to several recommendations for improvement of the protocol.
Conclusion: A protocol for attaining a reference diagnosis based on expert panel consensus was shown feasible in
research practice
Surface reaction probability during fast deposition of hydrogenated amorphous silicon with a remote silane plasma
- …